Richards, Merrill & Peterson, Inc. Eli Lilly & CO Transaction History
Richards, Merrill & Peterson, Inc.
- $191 Billion
- Q4 2024
A detailed history of Richards, Merrill & Peterson, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Richards, Merrill & Peterson, Inc. holds 568 shares of LLY stock, worth $486,889. This represents 0.23% of its overall portfolio holdings.
Number of Shares
568Holding current value
$486,889% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding LLY
# of Institutions
4,250Shares Held
756MCall Options Held
10.1MPut Options Held
11.4M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$83.1 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA74.2MShares$63.6 Billion1.03% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$56.5 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$44 Billion26.72% of portfolio
-
State Street Corp Boston, MA34.3MShares$29.4 Billion1.07% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $814B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...